The European pen needle market is anticipated to grow at a CAGR of 7.7% during the forecast period. The growth of the market is attributed to the easy availability of such devices owing to the strong presence of various global companies such as B. Braun Melsungen AG, Novo Nordisk A/S, Smiths Group Plc. and Vygon SA.    Additionally, the significant increase in the number of diabetes...